These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3234424

  • 1. DNA profile and steroid receptor content of human ovarian cancer.
    Jakobsen A, Hansen V, Poulsen HS.
    Eur J Gynaecol Oncol; 1988; 9(6):461-3. PubMed ID: 3234424
    [Abstract] [Full Text] [Related]

  • 2. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE, Klemi P, Toikkanen S, Kaihola HL, Laippala P, Mäenpää J, Mäkinen J, Grönroos M.
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [Abstract] [Full Text] [Related]

  • 3. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
    Heinonen PK, Mörsky P, Aine R, Koivula T, Pystynen P.
    Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
    [Abstract] [Full Text] [Related]

  • 4. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
    Grénman SE, Klemi P, Toikkanen S, Irjala K, Laippala P, Vähä-Eskeli K, Mäenpää J, Salmi T.
    Ann Chir Gynaecol Suppl; 1994 Mar; 208():10-4. PubMed ID: 8092757
    [Abstract] [Full Text] [Related]

  • 5. The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors.
    Friedlander ML, Quinn MA, Fortune D, Foo MS, Toppila M, Hudson CN, Russell P.
    Gynecol Oncol; 1989 Feb; 32(2):184-90. PubMed ID: 2910780
    [Abstract] [Full Text] [Related]

  • 6. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
    Leers MP, Nap M.
    Breast J; 2001 Feb; 7(4):249-59. PubMed ID: 11678803
    [Abstract] [Full Text] [Related]

  • 7. Cytoplasmic steroid receptors in ovarian tumours.
    Quinn MA, Pearce P, Rome R, Funder JW, Fortune D, Pepperell RJ.
    Br J Obstet Gynaecol; 1982 Sep; 89(9):754-9. PubMed ID: 7115640
    [Abstract] [Full Text] [Related]

  • 8. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW.
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [Abstract] [Full Text] [Related]

  • 9. Estrogen and progesterone receptors in human ovarian tumors.
    Willcocks D, Toppila M, Hudson CN, Tyler JP, Baird PJ, Eastman CJ.
    Gynecol Oncol; 1983 Oct; 16(2):246-53. PubMed ID: 6313494
    [Abstract] [Full Text] [Related]

  • 10. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE, Gershteĭn ES, Smirnova KD, Murav'eva NI, Kuz'mina ZV.
    Vopr Onkol; 1984 Oct; 30(12):36-40. PubMed ID: 6516272
    [Abstract] [Full Text] [Related]

  • 11. Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.
    van Doorn HC, Burger CW, van der Valk P, Bonfrèr HM.
    J Clin Pathol; 2000 Mar; 53(3):201-5. PubMed ID: 10823139
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.
    Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, Berens ME.
    Cancer; 1989 Jan 15; 63(2):280-8. PubMed ID: 2910432
    [Abstract] [Full Text] [Related]

  • 13. Sex steroid hormones and receptors in relation to S-phase fraction and ploidy level in endometrial carcinoma.
    Boman K, Mäentausta O, Bäckström T, Strang P, Stendahl U.
    Anticancer Res; 1995 Jan 15; 15(3):999-1002. PubMed ID: 7645992
    [Abstract] [Full Text] [Related]

  • 14. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
    Leers MP, Schutte B, Theunissen PH, Ramaekers FC, Nap M.
    Hum Pathol; 2000 May 15; 31(5):584-92. PubMed ID: 10836298
    [Abstract] [Full Text] [Related]

  • 15. DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma.
    al-Alwan NA.
    East Mediterr Health J; 2000 May 15; 6(5-6):1062-72. PubMed ID: 12197329
    [Abstract] [Full Text] [Related]

  • 16. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content.
    Iversen OE, Skaarland E, Utaaker E.
    Gynecol Oncol; 1986 Jan 15; 23(1):65-76. PubMed ID: 3943754
    [Abstract] [Full Text] [Related]

  • 17. DNA flow cytometry in uterine endometrial carcinoma.
    Jacobsen M, Høyer M, Bentzen SM, Nielsen K.
    APMIS Suppl; 1991 Jan 15; 23():107-12. PubMed ID: 1883634
    [Abstract] [Full Text] [Related]

  • 18. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
    Geyer H, Teufel G, de Gregorio G, Pfleiderer A.
    Onkologie; 1984 May 15; 7 Suppl 2():44-52. PubMed ID: 6379538
    [Abstract] [Full Text] [Related]

  • 19. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
    Teufel G, Geyer H, de Gregorio G, Fuchs A, Kleine W, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1983 Dec 15; 43(12):732-40. PubMed ID: 6559148
    [Abstract] [Full Text] [Related]

  • 20. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
    Zubrikhina GN, Kuz'mina EV, Bassalyk LS, Murav'eva NI.
    Vopr Onkol; 1989 Dec 15; 35(10):1179-86. PubMed ID: 2596061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.